top of page


Continuing Education

Wolters Kluwer and DoseMeRx; presentations by Kristi Kuper, PharmD, BCPS, FIDSA, CMWA, and Steve Mok, PharmD, BCPS, BCIDP

Goals: Discuss the complexity of AUC dosing workflows and the benefits of Bayesian dosing for vancomycin, Explore how pharmacy teams are adopting Bayesian dosing tools to streamline workflows, allow automated access to faster, more precise calculations, and proactively monitor therapy to reduce a patient’s risk of acute kidney injury (AKI), Discover best practices for standardizing care with a data-driven approach to dose optimization and keeping prescribing in line with your hospital’s antimicrobial stewardship goals and the CDC’s Core Elements, Demonstrate how with a single click, pharmacists can automatically calculate patient specific vancomycin dose recommendations to achieve a target AUC using key clinical data such as patient demographics,, laboratory values, and previous vancomycin doses given.


American Society for Microbiology: Editors in Conversation; hosted by Cesar A. Arias, MD, MSc, PhD, with presentations by Dr. Catherine Liu, MD, and Michael J. Rybak, PharmD, MPH, PhD

AJHP Voices; Moderated by William Zellmer, BSPharm, MPH, Contributing editor of AJHP with presentations by Jennifer Le, PharmD, MAS, FIDSA, FCCP, HCSHP, BCPS-ID, and Michael J. Rybak, PharmD, MPH, PhD


InsightRx Inc.; presentations by Sirj Goswami, PhD, Dan D’Orazio, Rita Jew, PharmD, FASHP, Julia Giddens, PharmD, BCPS-AQID, BCIDP, Jeffery Laux, PharmD, BCIDP


Goals: Discuss benefits and challenges of adopting the new guidelines amid the COVID-19 pandemic, review benefits of precision dosing on cost, patient safety and pharmacist workflow.

InsightRx Inc.; presentation by Jon Faldasz, PharmD, BCPS


Goals: Review major guideline updates, discuss preference of Bayesian-guided dosing and outline practical steps to implement guidelines.

InsightRx Inc.; presentation by Jon Faldasz, PharmD, BCPS


Goals: Review vancomycin AUC dosing options.

InsightRx Inc. and Premier Inc.; presentations by Michael J. Rybak, PharmD, MPH, PhD and Stacey Whitcomb, CIC, CLS


Goals: assess how AUC standardizes pharmacokinetic dosing and minimizes adverse events, discuss optimization of cost of care through fewer lab sample draws and review integration of AUC dosing into TheraDoc® workflow

ClinCalc; presentation by Sean P. Kane, PharmD, BCPS


Goal: review the basics of using Bayesian modeling to more accurately dose vancomycin

Contagion; presentation by Mario V. Beccari, PharmD, BCPS, AAHIVP

Contagion; presentation by Matthew Girgis, PharmD


The information provided by the MAD-ID Vancomycin Task Force (“we,” “us” or “our”) on this website (the “Site”) is for general informational purposes only. All information on the Site is provided in good faith, however we make no formal endorsement(s) of any kind regarding use of any proprietary materials found within this content. Under no circumstance shall we have any liability to you for any loss or damage of any kind incurred as a result of the use of the site or reliance on any information provided on the site. Your use of the site and your reliance on any information on the site is solely at your own risk.

bottom of page